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With progress in magnetic resonance imaging technology and a broader dissemination of state-of-the-
art imaging facilities, the acquisition of multiple neuroimaging modalities is becoming increasingly 
feasible. One particular hope associated with multimodal neuroimaging is the development of reliable 
data-driven diagnostic classifiers for psychiatric disorders, yet previous studies have often failed to find 
a benefit of combining multiple modalities. As a psychiatric disorder with established neurobiological 
effects at several levels of description, alcohol dependence is particularly well-suited for multimodal 
classification. To this aim, we developed a multimodal classification scheme and applied it to a rich 
neuroimaging battery (structural, functional task-based and functional resting-state data) collected 
in a matched sample of alcohol-dependent patients (N = 119) and controls (N = 97). We found that 
our classification scheme yielded 79.3% diagnostic accuracy, which outperformed the strongest 
individual modality – grey-matter density – by 2.7%. We found that this moderate benefit of multimodal 
classification depended on a number of critical design choices: a procedure to select optimal modality-
specific classifiers, a fine-grained ensemble prediction based on cross-modal weight matrices and 
continuous classifier decision values. We conclude that the combination of multiple neuroimaging 
modalities is able to moderately improve the accuracy of machine-learning-based diagnostic 
classification in alcohol dependence.
In recent years, technical advancements in magnetic resonance imaging (MRI) technology and increasing access 
to these state-of-the-art MRI facilities for both clinicians and researchers have nourished the quest for MRI-based 
diagnostic classifiers of psychiatric disorders that proceed in an automated and objective manner. In addition, 
multiple MRI modalities, including high-resolution structural images, resting-state connectivity maps, white 
matter tractography based on diffusion tensor imaging and functional MRI, are now readily available as part of 
standard experimental protocols. The hope associated with such multimodal MRI batteries is that measurements 
targeting different levels of brain structure and function will, in combination, lead to a breakthrough in the quan-
titative characterization of psychiatric disorders1–3.
A limiting factor in this endeavour is that most psychiatric disorders have an upper bound for the accuracy of 
machine-learning-based diagnostic classification imposed by (1) ‘label noise’ of psychiatric diagnoses, evidenced 
by often poor inter-rater reliabilities4,5, and (2) an intrinsic heterogeneity of psychiatric diagnostic labels them-
selves6–8. It is therefore no surprise that the most successful applications of (multimodal) MRI-based machine 
learning have been achieved in disorders involving clear neurodegenerative effects such as Alzheimer’s disease9–12 
or multiple sclerosis13,14.
Here, we reasoned that alcohol dependence is a well-suited psychiatric disorder for automated diagnostic clas-
sification based on multimodal MRI and an ideal test case and benchmark for methodological developments. This 
is first and foremost because neurobiological correlates of alcohol dependence have been established at several 
levels of description, including grey-matter loss15–18, increased ventricular size/cerebrospinal fluid concentra-
tion19–21 and aberrant neural reward responses22–25. The diversity of effects in combination with a high degree of 
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replicability could make the combination of different MRI modalities particularly powerful in the case of alcohol 
dependence. In addition, alcohol dependence, relative to other psychiatric disorders, is a reliable diagnosis26–28 
and thus a paradigmatic case to gauge the true predictive potential of an MRI-based classifier for psychiatric 
diagnosis.
Our investigation was based on a sample of 119 alcohol-dependent patients and 97 controls who underwent 
an extensive neuroimaging battery including structural16,29, functional30–32 and resting-state33 MRI as part of the 
LeAD study (www.lead-studie.de; clinical trial number: NCT01679145). Our guiding rationale for the construction 
of a multimodal diagnostic classifier was clinical utility and practicability, and thus to leverage on neuroimaging 
modalities that are effective and simple to acquire (i.e., relatively short acquisition times and standard scanning 
sequences) and to analyse (e.g. no computational cognitive modelling or other approaches rich on assumptions). 
Selected modalities comprised grey-matter density, cerebral spinal fluid and cortical thickness based on structural 
MRI as well as basic reward responses and resting-state connectivity based on functional MRI.
Our goal was to address key methodological challenges of multimodal MRI, such as the heterogeneity of 
different modalities in terms of statistical properties and the number of predictors, missing data in one or more 
modalities, and the relative weighting of each modality. In the present investigation we thus developed a novel 
classification framework that (1) combined modality-specific predictions in an ensemble vote, (2) allowed for 
emphasizing or de-emphasizing individual modalities through weighting, (3) considered fine-grained informa-
tion from modality-specific classifiers instead of binary labels, and (4) was robust to missing data in individ-
ual modalities. We hypothesized that the combination of MRI modalities for diagnostic classification of alcohol 
dependence would outperform any individual unimodal classification approach.
Method
Participants. This study was conducted as part of the Learning and Alcohol Dependence (LeAD) study, a 
German (Berlin, Dresden) program investigating the neurobiological basis of alcohol dependence (www.lead-
studie.de; clinical trial number: NCT0167914530,34,35). We assessed 119 individuals aged 20–65 (18 female) meet-
ing criteria of alcohol dependence according to ICD-10 and DSM-IV-TR (American Psychiatric Association 
2000) and 97 healthy controls aged 21–65 (16 female) matched in terms of age, gender and smoking (see Table 1).
We used the computer-assisted interview version Composite International Diagnostic Interview 
(CAPI-CIDI36,37) to verify diagnosis criteria of AD in the patient group and to exclude the possibility of AD in 
control subjects. For inclusion, individuals with AD had to meet criteria for AD for at least three years and had to 
undergo an inpatient detoxification phase (average duration ± SEM: 22.8±1 days). Exclusion criteria for all sub-
jects were left-handedness (Edinburgh handedness index below 5038), contraindications for MRI, and a history of 
or current neurological (including Korsakoff syndrome) or mental disorders (excluding nicotine dependence in 
both groups and alcohol abuse in individuals with AD, but including abuse of other drugs). Mental disorders were 
AD (N = 119) HC (N = 97)
t or 𝜒2 df pMean SD % Mean SD %
Gender [female] 15.1 16.5 0.008 N = 216 0.93
Age [years] 45.0 10.7 43.6 10.8 0.9 214 0.38
Education [years] 10.5 0.1 11.2 0.2 −3.4 207 <0.001
SES −0.4 0.2 0.7 0.3 −3.6 170 <0.001
Smokers 76.5 67.0 1.9 N = 216 0.16
ADS score 14.8 6.9 2.0 3.0 17.0 213 <0.001
AD duration [years] 11.7 9.9 N = 110
Amount life [kg] 1805 1121 286 811 11.1 214 <0.001
Amount past year [kg] 178 13 11 1 12.0 214 <0.001
OCDS total score 11.9 8.5 2.8 2.8 10.1 207 <0.001
BIS-15 total score 31.6 6.5 29.1 5.5 2.9 205 0.004
TMT (percentile) 36.1 25.1 44.8 25.1 2.5 209 0.014
DSST 64.3 15.1 73.5 16.6 4.2 211 <0.001
DSB 6.5 1.9 7.4 2.0 3.4 214 0.001
MWT 104.7 9.4 104.5 8.9 −0.2 209 0.82
Wordlist 90.8 16.1 90.9 14.1 −0.0 209 0.97
Table 1. Sample characteristics for alcohol-dependent (AD) and healthy control (HC) subjects. Socioeconomic 
status (SES): sum of z-transformed self-ratings of social status, household income and inverse personal debt 
scores98; Alcohol Dependence Scale (ADS): degree/level of AD99; Amount life: lifetime alcohol consumption in 
kilograms based on the CAPI-CIDI (Wittchen and Pfister, 2007; Jacobi et al., 2013); Amount past year: alcohol 
consumption during the past year in kilograms based on the CAPI-CIDI (Wittchen and Pfister, 2007; Jacobi  
et al., 2013); Obsessive Compulsive Drinking Scale (OCDS): Current craving for alcohol100; Barratt 
Impulsiveness scale (BIS-15): impulsivity101; Trail making test (TMT; percentile): visual attention and task 
switching102; Digit symbol substitution test (DSST): processing speed103. Digit span backwards (DSB): working 
memory span103. Multiple-choice vocabulary intelligence test (Mehrfachwahl-Wortschatz-Intelligenztest, 
MWT): crystallized / verbal intelligence104; Wordlist (savings): wordlist memory test105.
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assessed according to DSM-IV axis one as verified by the CAPI-CIDI. It was ensured that all subjects were free of 
psychotropic medication (including detoxification treatment) known to interact with the central nervous system 
for at least four half-lives. Current non-alcohol drug abuse was confirmed by means of a dedicated urine test.
Note that several sampling characteristics were influenced by the fact that predictors of relapse, while not 
part of the present work, were another research focus within the LeAD study30: (1) to have sufficient power for 
the comparison between relapsers and abstainers, the AD group was oversampled relative to the HC group; (2) 
to be able to study relapse behaviour, detoxification at baseline was an inclusion criterion; (3) to prevent the pos-
sibility that handedness would be unequally distributed across relapsers and abstainers, only right handers were 
included. Finally note that matching for smoking implied a higher proportion of smokers in the HC sample than 
expected from a representative sample (67% versus a representative prevalence of 28% in Germany39).
Participants gave written informed consent. Ethical approval for the study was obtained from both sites 
(Ethics committee of the Universitätsklinikum Dresden/Technische Universität Dresden, EK 228072012; Ethics 
committee of Charité–Universitätsmedizin Berlin, EA 1/157/11), and procedures were in accordance with the 
Declaration of Helsinki.
Overview of neuroimaging modalities. To maximize the clinical utility of a multimodal diagnostic clas-
sifier, we constructed a neuroimaging battery of five modalities that was (1) simple to acquire and to analyse, 
and (2) based on established effects either in previous literature or on own works within the LeAD program. 
From structural MRI measurements we derived three modalities: (1) grey-matter density, as damaging effects to 
grey-matter integrity in chronic alcoholics have been replicated numerous times in the literature15,17,18 includ-
ing our own work in which we also demonstrated high diagnostic discriminability16; (2) cerebrospinal fluid, as 
increased ventricular size (or increased cerebrospinal fluid, respectively) is arguably one the most salient charac-
teristics of alcoholic brains19–21; and (3) cortical thickness, an additional specific marker of grey-matter integrity 
obtained through surface-based analysis, which has been successfully used in more recent studies to characterize 
structural damage in alcohol dependence40–42.
From task-based functional MRI we obtained (4) functional activation patterns representing a basic reward 
response (outcome versus no outcome), motivated by the fact that aberrant functional reward responses have 
been consistently found for alcohol dependence22–25. Finally, from resting-state functional MRI, we derived (5) 
nucleus accumbens whole-brain connectivity maps, as one of the key research goals of the LeAD program was 
testing a hypothesis about disturbed striato-frontal connectivity underlying the development of problematic 
drinking behaviours (this hypothesis has recently been confirmed by authors of this article33). Note that all data 
were linearly corrected for variance of no interest related to demographic variables age, gender and site.
MRI data acquisition. Magnetic resonance imaging (MRI) was performed on a 3-Tesla Siemens Trio 
(Erlangen, Germany) scanner with a 12-channel head-coil to obtain (1) structural, (2) functional task-based 
and (3) functional resting-state MRI data. Structural T1-weighted MRI scans were acquired using a 
magnetization-prepared rapid gradient echo sequence (repetition time: 1900 ms; echo time: 5.25 ms; flip angle: 
9°; field of view: 256 × 256 mm2; voxel size: 1 mm isotropic; 192 sagittal slices). Functional (task-based or 
resting-state) T2*-weighted MRI scans were acquired using a gradient echo planar imaging sequence (repetition 
time: 2410 ms; echo time: 25 ms; flip angle: 80°; field of view: 192 × 192 mm2; voxel size: 3 × 3 × 2 mm3) com-
prising 42 slices approximately −25° to the bicommissural plane. Volume-to-volume movement of more than 
3 mm translation and/or 2 degrees rotation led to exclusion (9 HC and 12 AD subjects were excluded due to these 
criteria). All imaging data were screened for corrupted data or serious acquisition artefacts.
MRI preprocessing and feature preparation. Neuroimaging features from overall five modalities were 
computed: grey-matter density (GMD), cerebrospinal fluid (CSF) and cortical thickness (CTH) from structural 
MRI; a basic reward response (RWR) signal from task-based functional MRI and nucleus accumbens connectiv-
ity (NAC) from resting-state functional MRI. In the following we describe the steps involved in preprocessing and 
feature preparation for each modality.
Structural MRi. Structural MRI images were processed in two separate analyses streams for GMD/CSF 
and CTH. For GMD/CSF, SPM12 (http://www.fil.ion.ucl.ac.uk/spm) was used in combination with voxel-based 
morphometry (VBM8; http://dbm.neuro.uni-jena.de/vbm). T1-weighted Images were spatially normalized to a 
Montreal Neurological Institute (MNI) template and segmented based on tissue types. Unmodulated images rep-
resenting GMD and CSF density were smoothed with an 8 mm isotropic Gaussian kernel. To reduce dimension-
ality, 110 regional averages for both GMD and CSF were computed based on a combined cortical and subcortical 
anatomical brain atlas16,43.
To obtain estimates of CTH, cortical reconstruction was performed on T1-weighted images using the 
FreeSurfer morphometric analysis suite (http://surfer.nmr.mgh.harvard.edu/). The technical details of these pro-
cedures are described in prior publications44–55. CTH estimates were obtained by calculating the closest distance 
from the grey/white boundary to the grey/CSF boundary at each vertex on the tessellated surface45. Average cor-
tical thickness estimates were obtained for 358 brain regions based on the Glasser anatomical atlas56.
Task-based functional MRI. Preprocessing was performed using SPM8 (www.fil.ion.ucl.ac.uk/spm) and 
included slice time correction, realignment to the first image, coregistration with the structural image, spatial 
normalization into MNI space and smoothing (8 mm Gaussian kernel). Details of the paradigm and the statistical 
first-level model have been provided elsewhere30. In brief, the paradigm involved a probabilistic value-based deci-
sion making task57 in which participants could receive a fixed monetary reward in each of 201 trials. While the 
goal of the paradigm is to distinguish model-based from model-free learning signals by means of a computational 
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model, following our rationale of constructing a neuroimaging battery with only the most fundamental modali-
ties, we here used the basic contrast of reward (+20 Euro cents) versus no reward.
Within the statistical first-level model30, we used the two onset regressors for reward and no-reward conditions 
during the outcome phase and computed directional contrasts (reward > no reward). To reduce the extremely 
high dimensionality of individual fMRI whole-brain contrast maps (>200.000 valid voxels), we downsampled 
the data to 10 mm isotropic voxels resulting in 1461 valid voxels (features) for each participant. Exploratory clas-
sification analyses with smaller voxels sizes (2–8 mm in steps of 2 mm) showed that no relevant information was 
lost at 10 mm.
Resting-state functional MRI. Preprocessing of resting-state data was performed using FSL (https://
www.fmrib.ox.ac.uk/fsl) and included motion correction, slice timing correction, non-brain removal, 6 mm 
FWHM spatial smoothing. Data were denoised using independent component analysis (ICA-AROMA58,59), 
high-pass-filtered at 0.008 Hz and normalized to MNI space. To estimate whole-brain accumbens connectiv-
ity maps, binary seed masks of the left and right nucleus accumbens were defined using the Harvard-Oxford 
Subcortical Probability Atlas (50% probability threshold). The first Eigen time series was extracted from the pre-
processed resting-state data, separately for the left and right nucleus accumbens. Finally, these time series were 
regressed against every other voxel’s time series using deep white matter and CSF as nuisance variables. To reduce 
dimensionality, we computed regional averages for the 110 anatomical regions of the JHU brain atlas43 and aver-
aged across the left and right nucleus accumbens. Note that while participants were excluded when falling asleep 
during scanning, part of the interindividual variance in resting state connectivity may be explained by unknown 
interindividual differences in drowsiness/vigilance, which were not assessed in an objective manner in the current 
study. Nevertheless, only a small number of participants (7 AUD and 6 HC) reported brief moments of drowsi-
ness or loss of vigilance during the exit interview.
Unimodal diagnostic classification. In a first step, the diagnostic accuracy of each of the five modalities 
was assessed. Before submitting the modalities to classification, each modality was soft-normalized by removing 
the median and scaling the data according to a quantile range (1% to 99%)60. We considered two different clas-
sifier types: support vector machine (SVM61) and weighted robust distance (WeiRD16,62,63). SVM is arguably the 
most popular classifier in the context of neuroimaging64, as it robustly handles data with high dimensionality 
but few samples per class. We used the implementation provided by libsvm65 with a radial basis function ker-
nel. WeiRD is a distance-to-centroid classifier (code available at https://github.com/m-guggenmos/weird), which 
assigns class labels based on the Manhattan distance to class prototypes in a statistically weighted feature space. 
A key advantage of WeiRD is the fact that it is parameter-free and hence does not require expensive optimization 
schemes. In previous work we have shown that WeiRD, despite its simplicity, performs surprisingly well across a 
range of neuroimaging classification problems16,62,63.
Both classifiers operated in a leave-one-out (LOO) cross-validation procedure, such that in each 
cross-validation fold, the classifiers were trained on the data of all but one participant and tested on the left-out 
participant. Each participant was left out and predicted exactly once. LOO was chosen over other cross-validation 
schemes, because it is approximately unbiased66, deterministic and computationally inexpensive. For SVM spe-
cifically, we additionally performed nested cross-validation and grid search to optimize the cost parameter C 
(range of C: 2x, x = −5:1:10). We used the balanced accuracy as a scoring metric and computed p-values of the 
null hypothesis that the balanced accuracy is equal to chance level67.
Note that the number of features outnumbered the number of samples. This is the standard scenario in multi-
variate neuroimaging analyses, which have been widely used with success to fit machine learning models within 
and across individuals68,69, most likely due to intercorrelations between features70.
In addition, we assessed the importance of each region for classification. For clarity and brevity, we show 
importance scores only for the superior classifier (SVM or WeiRD) of a modality. Where SVM was superior, we 
derived importance scores from the hyperplane-defining weight vector in feature space. Although the feature 
space is not the input space in the case of the radial-basis function kernel used here, the weights in feature space 
nevertheless provided a useful estimate of feature importance for descriptive purposes. Where WeiRD was supe-
rior, we used WeiRD votes as a measure of feature importance, as described previously16.
Multimodal diagnostic classification. The aim of multimodal neuroimaging classification is to improve 
overall performance by leveraging on the combined information of more than one neuroimaging modality. Here 
we combined all five modalities introduced above (GMD, CSF, CTH, RWR, NAC) in an integrated classifica-
tion scheme. The key design principle for the multimodal classification scheme was that a separate classifier was 
trained on each modality, which made it possible to select the optimal classifier for each modality and to fit it to 
the specific statistical properties of a modality.
As for unimodal classification, multimodal classification was based on soft-normalised data and proceeded 
in a LOO cross-validation procedure. In the multimodal scenario this meant that in each cross-validation fold, 
all data (i.e. all modalities) of one participant were left out for independent testing. Henceforth, we describe the 
analytic work-flow of training and prediction for one such fold (see also Fig. 1).
training. During training, a separate classifier was trained on each modality and three factors were opti-
mized in a nested cross-validation procedure: the classifier type (SVM or WeiRD); the parameters of a classifier 
if applicable (cost parameter C for SVM); and modality-specific weights. In detail, for each modality separately 
it was first assessed whether SVM (with second-level-nested cross-validation for the optimization of C) or 
WeiRD were more accurate on the training data set. If SVM was superior, the optimal cost parameter was then 
estimated anew on the entire training data. After determining the optimal classifier for each modality, a new 
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nested cross-validation procedure was performed for all modalities combined to estimate weighting factors for 
each modality. To limit computational complexity and increase robustness, each of the five modalities could be 
weighted only with a factor of either 1 or 2.
prediction. After training, the classification scheme was applied to the yet unseen test subject. Each 
modality-specific classifier computed a signed continuous decision value for the respective modality, where neg-
ative and positive values represented control and patient predictions and the absolute value the certainty of a 
classifier. The overall ensemble prediction was based on the sign of a weighted sum of modality-specific decision 
values with weighting factors determined during training.
To assess the effect of optimizing the classifier and the weighing scheme, the entire procedure was performed 
with either fixing the classifier to either WeiRD or SVM (but still optimizing C), and/or omitting modality weight-
ing, i.e. fixing all weights to 1.
Finally, note that a key advantage of our classification scheme was that missing data were of no concern: if 
a subject had missing data for a modality (see Table 2 for the number of valid samples in each modality), this 
modality was simply omitted from the weighted sum of modality-specific decision values for the given subject.
Results
Unimodal diagnostic classification. Three reasons motivated an initial assessment of unimodal classifica-
tion, i.e. classification based on each modality individually. First, to provide a reference against which multimodal 
classification could be benchmarked. Second, to elucidate for each modality which brain regions contained infor-
mation predictive of diagnosis. And third, to assess the agreement between different modalities with respect to 
patient/control predictions (inter-modality reliability).
We found that each modality discriminated significantly between patients and controls (Table 3), although 
the accuracy varied strongly across modalities. For both SVM and WeiRD, grey-matter density was the 
Figure 1. Multimodal classification scheme. Depicted is one exemplary split into training data and test data. 
Using a nested optimization loop, three modality-specific factors are optimized on the training data: classifier 
types (SVM, WeiRD), parameters (cost parameter C for SVM) and weights wi. The trained and optimized 
model is then applied to the test data and continuous decision values di are computed for each modality-specific 
classifier. The final diagnostic classification is based on a weighted sum of decision values, where weights 
correspond to those estimated during training.
Time Modality Short NCtr NPat No. features
sMRI
4:26 Grey-matter density GMD 97 119 110
Cerebrospinal fluid CSF 97 119 11
Cortical thickness CTH 96 119 358
Task-based fMRI 22:10 Reward response RWR 74 80 1461
Resting-state fMRI 6:02 Nucleus accumbens connectivity NAC 84 93 110
Table 2. Overview of modalities. Columns represent acquisition time, shortcuts for each modality used 
throughout the article, the number of control (NCtr) and patients (NPat) available for each modality, and the 
numbers of features per modality (No. features).
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best-performing modality with balanced accuracies of 76.6% and 71.3%, respectively. All other modalities 
ranged between 55 and 66% accuracy. The balance between specificity and sensitivity was heterogenous across 
modalities. For instance, while cortical thickness was more sensitive than specific, cerebrospinal fluid and reward 
responses showed an opposite pattern.
To investigate which brain regions contributed to classification, we inspected feature importances for each 
modality (Fig. 2A,B and Supplementary Fig, S1). Across modalities, we found that anterior cingulate and inferior 
frontal brain regions discriminated best between patients and controls. This included the cerebrospinal fluid, for 
which the (left) frontal ventricle was most discriminative. These results are broadly in line with the hypothesis of 
prefrontal cortex dysfunction in addiction71–73. In addition, for functional reward responses the nucleus accum-
bens was the second most discriminative brain region (after subcallosal anterior cingulate cortex), a key region 
of generic reward pathways74 and of bottom-up theories of addiction such as the incentive-sensitization theory22. 
Although not the focus of this study, the brain regions that discriminate best between patients and controls map 
well on established neural correlates of alcohol dependence75,76 and provide validation to the approach taken in 
this study.
Our initial unimodal analysis of feature importances showed that informative features were primarily located 
in prefrontal and cingulate brain regions (for strctural and connectivity measures) as well as in the nucleus 
accumbens (for reward responses).
How well do different modalities agree with respect to their diagnostic predictions? To find out, we computed 
inter-modality reliability scores based on Cohen’s Kappa77, which measures the agreement of two “raters” over 
and above the agreement expected by chance. For each modality we used the classifier (SVM or WeiRD) that per-
formed better for a given modality. As shown in Fig. 2C, the agreement was generally highest between modalities 
based on structural MRI. Within those, predictions based on grey-matter density and cerebrospinal fluid showed 
the highest agreement with a Kappa value of 0.4 (considered a ‘moderate‘ agreement78). All other modality com-
parisons exhibited relatively little agreement with Kappa values <= 0.25. Across all modalities, predictions based 
on nucleus accumbens connectivity showed the least agreement with any other modality.
Multimodal diagnostic classification performs better than each individual modality. To com-
bine modalities for multimodal classification, we trained individual classifiers on each modality separately, 
computed predictions based on each modality, and then combined these predictions in the form of a weighted 
ensemble vote (Fig. 1). A number of details of this analytic framework deserve highlighting. First, classifiers were 
optimized for each modality individually, both with respect to the classifier type (SVM or WeiRD) and in terms 
of a modality-specific regularization parameter (C in the case of SVM). Second, instead of relying on discrete 
predictions, continuous decision values were computed for each modality, which enabled a more fine-grained 
ensemble decision. Third, on top of these intrinsic classifier-based decision values, an external weighting matrix 
across modalities was learned from the training data, further refining the ensemble vote.
Employing this fully-featured multimodal classification scheme yielded a balanced accuracy of 79.3% 
(p < 10−18). Thus, combining the information from multiple modalities improved the accuracy compared to the 
best individual modality (grey-matter density: 76.6%). An analysis of sensitivity and specificity showed that this 
improvement was due to an increase of specificity (81.3%; sensitivity: 77.3%), which reached a level unmatched 
by any individual modality.
To investigate which analytic component of the multimodal classification scheme was essential for this 
improvement – or which aspect may have been redundant – we computed accuracies while muting one or more 
of the features. As shown in Fig. 3, we found that indeed each analytic component discussed above (optimization 
of classifiers, decision values instead of discrete predictions, cross-modal weighting) was responsible for an incre-
mental improvement of performance. Of these, the largest improvement was due to considering continuous deci-
sion values instead of binary “control” and “patient” predictions (represented by red lines in Fig. 3): without this 
feature, the multimodal accuracy would have dropped below the best individual modality, even if classifiers and 
weights were optimized (75.4%). Overall, these results show that multimodal classification requires a nuanced 
integration of modalities in order to achieve a meaningful benefit.
To assess the significance of each individual modality for multimodal classification, we computed classifi-
cation accuracies while tentatively excluding each modality once. The results (Table 4) showed that the accu-
racy dropped in each case, indicating that each modality was important for overall multimodal performance. 
Not surprisingly, the sharpest drop in performance was observed when excluding the best individual modality, 
grey-matter density (−9.6%). In particular, grey-matter density was largely responsible for the high sensitivity of 
SVM WeiRD
Acc. Sens. Spec. P Acc. Sens. Spec. P
Grey-matter density 76.6 79.0 74.2 <0.001 71.3 66.4 76.3 <0.001
Cerebrospinal fluid 58.6 51.3 66.0 0.003 65.0 58.8 71.1 <0.001
Cortical thickness 54.9 58.8 51.0 0.037 65.6 69.7 61.5 <0.001
Reward response 60.2 47.5 73.0 0.002 59.3 55.0 63.5 0.005
NAcc connectivity 54.8 54.8 54.8 0.050 55.0 50.5 59.5 0.044
Table 3. Unimodal classification. Classification performance of the SVM and WeiRD classifiers for 
the five modalities under consideration. Abbreviations: Acc. = Balanced accuracy; Sens. = sensitivity; 
Spec. = specificity; NAcc = Nucleus Accumbens.
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multimodal classification, evidenced by a substantial drop of sensitivity when excluded (−18.1%). By contrast, 
the sharpest drop in specificity was found when excluding cerebrospinal fluid (−7.3%). Taken together, these 
results show that the success of multimodal classification was based on the combined information of all modali-
ties such that no single modality was effectively redundant.
Figure 2. Unimodal classification. Feature importances of (A) structural and (B) functional neuroimaging 
modalities. Depicted are 2-d projections (‘glass brains’) of feature importances along the x- and z-axis. Feature 
importances represent SVM weights (grey-matter density, reward response) or WeiRD votes (cerebrospinal 
fluid, cortical thickness, resting state) depending on which classifiers was superior for a given modality. 
(C) Inter-modality reliability matrix based on Cohen’s Kappa describing the diagnostic agreement between 
modalities.
Figure 3. Multimodal classification. Balanced accuracy for classification schemes based on different classifier 
configurations (SVM, WeiRD or optimized between SVM and WeiRD) and with uniform (i.e., all weights 
set to 1) or optimized weighting of modalities. Optimizing both classifiers and weighting yielded the best 
performance (highlighted in green). Red lines indicate the balanced accuracy when ensemble prediction was 
based on discrete “control” and “patient” judgements instead of continuous decision values. Error bars represent 
the 95% posterior probability interval67.
Acc. (Δ) Sens. (Δ) Spec. (Δ)
69.7 (−9.6) 59.2 (−18.1) 80.2 (−1.0)
75.3 (−4.0) 76.7 (−0.6) 74.0 (−7.3)
78.1 (−1.2) 75.8 (−1.5) 80.4 (−0.8)
77.0 (−2.3) 75.6 (−1.7) 78.4 (−2.9)
77.3 (−2.0) 77.3 (0.0) 77.3 (−3.9)
Table 4. Impact of excluding modalities. Performance of multimodal classification when leaving out each 
modality once (Δ = change with respect to the full model). Abbreviations: Acc. = Balanced accuracy; 
Sens. = sensitivity; Spec. = specificity; NAcc = Nucleus Accumbens.
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Discussion
In the present investigation we used structural, functional task-based and functional resting-state MRI to con-
struct a diagnostic machine-learning classifier for alcohol dependence. A novel multimodal classification scheme, 
in which modality-specific weightings and optimal classifiers were estimated from training data, slightly outper-
formed the strongest individual modality and achieved a balanced accuracy of 79.3%.
Our initial unimodal analysis of feature importances showed that informative features were primarily 
located in (orbito-)prefrontal and cingulate brain regions as well as in the nucleus accumbens (for basic reward 
responses). These foci are broadly in line with previous investigations into brain structure and function in alco-
hol dependence, which identified executive and reward networks as major neural circuits that are affected in 
patients75. Thus, our unimodal structural and functional data show diagnostic characteristics well in line with 
previous results. Despite the overlap of affected brain structures, none of these considered modalities was redun-
dant: multimodal classification accuracy was reduced for each modality that was tentatively excluded. Together, 
these exploratory analyses into individual modalities thus attest to 1) plausible unimodal between-group effects 
and 2) a sensible selection of modalities that leveraged on non-redundant sources of information.
In comparison to the best individual modality (grey-matter density with SVM: 76.6%), multimodal classifi-
cation yielded an improvement of 2.7% accuracy, corresponding to a net gain of 6 additional subjects that were 
correctly classified. This gain in accuracy was specifically due to an increase in specificity (81.3%), which was 
7% higher than for grey-matter density (74.2%). The specific increase of specificity is noteworthy, as we recently 
found a particular advantage of unimodal computer-based classification over human judgements with respect to 
sensitivity, while specificity was higher for the judgements of an experienced radiologist (81.4%16). Thus, when 
combining multiple modalities, computer-based classification matched human performance in terms of identify-
ing true negatives, thereby eliminating a weakness of unimodal classification.
Although the improvement in overall accuracy is modest at 2.7%, one important qualification is that the com-
parison to the best of several modalities is necessarily unfair due to selection bias; that is, it is likely that the accu-
racy of the best modality is – to some degree – inflated by noise. Besides this ‘double dipping’79 bias, even at 2.7% 
our observed benefit of multimodal classification is noteworthy, as many previous studies have failed to find any 
advantage of combining multiple modalities9,10,80,81. There is currently no consensus on why an effective combina-
tion of multiple MRI modalities appears to be a surprisingly intricate task. But clearly, the success of multimodal 
classification must depend on how individual modalities complement each other: if individual modalities per-
fectly agree with each other, they are effectively redundant and thus no multimodal benefit is expected; vice versa, 
if predictions of individual modalities are completely uncorrelated, there is no positive cumulative effect through 
the combination of modalities. In the present case, the agreement of predictions between different modalities was 
quite variable overall but tended towards low inter-modality reliabilities (Cohen’s Kappa scores up to 0.4), which 
reflects the moderate benefit of multimodal classification.
At a methodological level, we found a number of analytic choices to be critical for the integration of multiple 
modalities. First, as data from different modalities will naturally have different structural properties, it is likely 
that there is no single classifier type that fits all modalities. Yet, to our knowledge, while multimodal investigations 
often compare classifier types9,11,82, they do so by applying the same classifier to all modalities, i.e. they do not opti-
mize the classifier type in a modality-specific manner. Here we found that optimizing the classifier type for each 
modality was superior to using either SVM or WeiRD uniformly across modalities. Second, applying a weight 
matrix learned from training data to the ensemble prediction likewise increased the performance compared to 
unweighted integration. Although this particular aspect has been considered previously (e.g. by means of logistic 
regression on predictions of individual modalities11), our results corroborate the importance of this analytic step.
Third, the biggest gain in accuracy was owed to using continuous classifier decision values instead of discrete 
(binary) predictions. The benefit of decision values can be explained by the fact that for both SVM and WeiRD, 
decision values reflected the certainty of the classifier. Thus, more certain predictions factor in more strongly 
into the ensemble prediction and thereby improve the overall accuracy. Indeed, we have previously shown that 
valuable information is contained in unthresholded decision values of classifiers applied to neuroimaging data63. 
On the basis of our results we thus recommend to avoid discretizing modality-specific predictions and instead to 
utilize fine-grained information contained in classifier decision values.
Despite these methodological insights about combining multiple neuroimaging modalities from both struc-
tural and functional MRI, considering the fact that fMRI scanning was more time-consuming and involved more 
elaborate data analysis, the achieved improvement through fMRI must be debated in view of clinical practicabil-
ity and a cost-benefit analysis. In our view, several factors are important for fMRI to become part of a clinically 
realistic diagnostic imaging battery. First, an accuracy net gain in the order of a few percent is relatively small, 
given the additional effort of instructing and conducting a functional scan in addition to a structural scan. Thus, 
to justify task-based and resting-state fMRI measures, these must either be more sensitive – or more orthogonal 
to the information from structural MRI. Second, employed fMRI tasks have to be sufficiently brief. This would be 
a relatively simple optimization of the present imaging battery, as the basic reward signal used for classification 
was extracted from a relatively complex decision-making task which could be condensed substantially. Third, at 
present the analysis of functional MRI data is more laborious compared to the analysis of structural MRI data. 
However, with the development of standardized, efficient, and robust analysis protocols (e.g. fMRIprep83), fMRI 
could become a realistic option for day-to-day clinical diagnosis. In sum, in terms of direct clinical applicability, 
currently the most realistic neuroimaging-based classifier for AD may be unimodal based on structural MRI and 
grey-matter density specifically.
A number of limitations should be noted. First, our sample is predominantly male, which limits the general-
ization of our results to female patients. This may be especially relevant for the most predictive modality in our 
approach, grey-matter density, as numerous studies have shown greater sensitivity to the neurotoxic effects of 
alcohol on grey matter in women84–86. Second, we were not able to validate our results against an independent 
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sample, as the multimodal imaging battery employed by the LeAD study has no precedence in the AD literature. 
However, in previous work on unimodal imaging16 we found almost perfect generalization to an independent 
sample (original: 74%; generalization: 73%). Although these previous results cannot be directly extrapolated to 
our current work, we note that both investigations share major aspects of the methodology, including the use of 
the weighted robust distance classifier62 and cross-validation with nested cross-validation for tuning parameters.
Third, the selection of neuroimaging modalities is not exhaustive. While in the present work we focused on 
a parsimonious set of established but basic modalities, especially in the functional domain there is abundant 
literature on various functional correlates of causes, state markers (e.g. craving) and consequences in alcohol 
dependence75,87. For instance, the influential iRISA (impaired response inhibition and salience attribution) model 
proposes that disrupted function of the prefrontal cortex leads not only to attributing excessive salience to drugs 
and associated cues, but also impairs the ability to inhibit drug-related behaviours71. More complete neuroimag-
ing models of alcohol dependence could thus additionally consider a prefrontal functional correlate of cognitive 
control. Regarding functional connectivity, there is evidence that large-scale functional networks (e.g. default 
mode network or cognitive control network) explain a substantial amount of variance with respect to alcohol use 
severity and may as well be informative for diagnostic classification88. These large-scale networks were not con-
sidered in the present study and thus deserve further research in the context of diagnostic neuroimaging-based 
classification. Fourth, based on the cross-sectional design in this study one cannot infer whether the neurobi-
ological differences utilized by our classifier are causes, state markers or consequences of alcohol dependence 
(although see preliminary evidence for the latter possibility in Supplementary Fig. 2). Thus, our classifier provides 
no mechanistic insight into the pathogenesis of alcohol dependence. For instance, based on previous findings it is 
possible to that group differences in brain structure may be predominantly consequences of severe alcohol abuse, 
as these changes partially reverse during abstinence89–91; differences in brain function may, in turn, predispose 
for addiction or relapse from addiction30,92. From a strict machine-learning point of view, one may be tempted to 
treat the issue of mechanistic insight as secondary. However, although neural features that characterize a predis-
position are particularly valuable due to their prognostic potential, for diagnosis they bear the risk of misclassify-
ing healthy individuals that did not develop AD despite having a disadvantageous predisposition. Patients which 
developed AD without such a predisposition could likewise be misclassified due to these features. For this reason, 
the ‘chicken or egg’ causality dilemma is indeed relevant for machine-learning-based diagnosis and should be 
investigated in future longitudinal studies.
Finally, in view of modern frameworks of psychiatric disease such as the Research Domain Criteria (RDoC) 
project, in which psychiatric phenotypes are defined as “spanning the range from normal to abnormal”93,94, the 
present approach could be readily adapted to predict dimensional markers of disease. Analogous to the idea of a 
weighted voting scheme across classifiers applied here for the case of binary prediction, multiple modality-specific 
regression models would be trained and their outputs combined to form a continuous ensemble prediction. The 
ensemble prediction would likewise be based on a weighted (and normalized) sum of individual predictions. 
Conceivable dimensional markers for the case of alcohol dependence are the magnitude of craving in acute 
addiction95, biological markers such as serum levels of carbohydrate deficient transferrin (CDT) and gamma 
glutamyltransferase (GGT)96, or scores of clinical questionnaires such as the Alcohol Use Disorders Identification 
Test (AUDIT97). Overall, we conclude that the combination of multiple neuroimaging modalities is able to mod-
erately improve the accuracy of machine-learning-based diagnostic classification in alcohol dependence. Our 
results allow us to make several methodological recommendations for the exploitation and integration of different 
modalities with the goal to compute optimal ensemble predictions, thereby paving the way towards more effective 
multimodal neuroimaging classifiers. Yet, at present, given the strong predictive performance of grey-matter den-
sity alone and taking a cost-benefit analyses into account, we currently recommend to focus on structural MRI for 
the diagnostic classification of alcohol dependence.
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